ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cyclopentolate Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-5T8341
Home | Market Reports | Health| Vision Care
Global Cyclopentolate Market Insights Forecast to 2028
BUY CHAPTERS

Global Cyclopentolate Market Research Report 2025

Code: QYRE-Auto-5T8341
Report
July 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alcon
Novartis
Laboratório Edol
Cadila Healthcare
FDC
Dr. Gerhard Mann
Abdi Ibrahim
Laboratorios Sophia
Bausch and Lomb
Santen
Riemser Arzneimittel
TEVA
Akorn

Cyclopentolate Market Size

The global market for Cyclopentolate was valued at US$ 1239 million in the year 2024 and is projected to reach a revised size of US$ 1679 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Cyclopentolate Market

Cyclopentolate Market

Cyclopentolate is a muscarinic antagonist. It is commonly used as an eye drop during pediatric eye examinations to dilate the eye (mydriatic) and prevent the eye from focusing or accommodating (cycloplegic). Cyclopentolate or atropine can also be administered to reverse muscarinic and central nervous system effects of indirect cholinomimetic (anti-AChase) administration.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyclopentolate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclopentolate.
The Cyclopentolate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cyclopentolate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cyclopentolate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cyclopentolate Market Report

Report Metric Details
Report Name Cyclopentolate Market
Accounted market size in year US$ 1239 million
Forecasted market size in 2031 US$ 1679 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Patent
  • Generic
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Alcon, Novartis, Laboratório Edol, Cadila Healthcare, FDC, Dr. Gerhard Mann, Abdi Ibrahim, Laboratorios Sophia, Bausch and Lomb, Santen, Riemser Arzneimittel, Teva, Akorn
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cyclopentolate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cyclopentolate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Cyclopentolate Market growing?

Ans: The Cyclopentolate Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Cyclopentolate Market size in 2031?

Ans: The Cyclopentolate Market size in 2031 will be US$ 1679 million.

Who are the main players in the Cyclopentolate Market report?

Ans: The main players in the Cyclopentolate Market are Alcon, Novartis, Laboratório Edol, Cadila Healthcare, FDC, Dr. Gerhard Mann, Abdi Ibrahim, Laboratorios Sophia, Bausch and Lomb, Santen, Riemser Arzneimittel, Teva, Akorn

What are the Application segmentation covered in the Cyclopentolate Market report?

Ans: The Applications covered in the Cyclopentolate Market report are Mydriatic Agent, Muscarinic Receptor Antagonist

What are the Type segmentation covered in the Cyclopentolate Market report?

Ans: The Types covered in the Cyclopentolate Market report are Patent, Generic

Recommended Reports

Ophthalmic Drug Markets

Eye Disorders Treatment

Eye Care Products

1 Cyclopentolate Market Overview
1.1 Product Definition
1.2 Cyclopentolate by Type
1.2.1 Global Cyclopentolate Market Value Comparison by Type (2024 VS 2031)
1.2.2 Patent
1.2.3 Generic
1.3 Cyclopentolate by Application
1.3.1 Global Cyclopentolate Market Value by Application (2024 VS 2031)
1.3.2 Mydriatic Agent
1.3.3 Muscarinic Receptor Antagonist
1.4 Global Cyclopentolate Market Size Estimates and Forecasts
1.4.1 Global Cyclopentolate Revenue 2020-2031
1.4.2 Global Cyclopentolate Sales 2020-2031
1.4.3 Global Cyclopentolate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cyclopentolate Market Competition by Manufacturers
2.1 Global Cyclopentolate Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cyclopentolate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cyclopentolate Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cyclopentolate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cyclopentolate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cyclopentolate, Product Type & Application
2.7 Global Key Manufacturers of Cyclopentolate, Date of Enter into This Industry
2.8 Global Cyclopentolate Market Competitive Situation and Trends
2.8.1 Global Cyclopentolate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cyclopentolate Players Market Share by Revenue
2.8.3 Global Cyclopentolate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cyclopentolate Market Scenario by Region
3.1 Global Cyclopentolate Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cyclopentolate Sales by Region: 2020-2031
3.2.1 Global Cyclopentolate Sales by Region: 2020-2025
3.2.2 Global Cyclopentolate Sales by Region: 2026-2031
3.3 Global Cyclopentolate Revenue by Region: 2020-2031
3.3.1 Global Cyclopentolate Revenue by Region: 2020-2025
3.3.2 Global Cyclopentolate Revenue by Region: 2026-2031
3.4 North America Cyclopentolate Market Facts & Figures by Country
3.4.1 North America Cyclopentolate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cyclopentolate Sales by Country (2020-2031)
3.4.3 North America Cyclopentolate Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cyclopentolate Market Facts & Figures by Country
3.5.1 Europe Cyclopentolate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cyclopentolate Sales by Country (2020-2031)
3.5.3 Europe Cyclopentolate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cyclopentolate Market Facts & Figures by Region
3.6.1 Asia Pacific Cyclopentolate Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cyclopentolate Sales by Region (2020-2031)
3.6.3 Asia Pacific Cyclopentolate Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cyclopentolate Market Facts & Figures by Country
3.7.1 Latin America Cyclopentolate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cyclopentolate Sales by Country (2020-2031)
3.7.3 Latin America Cyclopentolate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cyclopentolate Market Facts & Figures by Country
3.8.1 Middle East and Africa Cyclopentolate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cyclopentolate Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cyclopentolate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cyclopentolate Sales by Type (2020-2031)
4.1.1 Global Cyclopentolate Sales by Type (2020-2025)
4.1.2 Global Cyclopentolate Sales by Type (2026-2031)
4.1.3 Global Cyclopentolate Sales Market Share by Type (2020-2031)
4.2 Global Cyclopentolate Revenue by Type (2020-2031)
4.2.1 Global Cyclopentolate Revenue by Type (2020-2025)
4.2.2 Global Cyclopentolate Revenue by Type (2026-2031)
4.2.3 Global Cyclopentolate Revenue Market Share by Type (2020-2031)
4.3 Global Cyclopentolate Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cyclopentolate Sales by Application (2020-2031)
5.1.1 Global Cyclopentolate Sales by Application (2020-2025)
5.1.2 Global Cyclopentolate Sales by Application (2026-2031)
5.1.3 Global Cyclopentolate Sales Market Share by Application (2020-2031)
5.2 Global Cyclopentolate Revenue by Application (2020-2031)
5.2.1 Global Cyclopentolate Revenue by Application (2020-2025)
5.2.2 Global Cyclopentolate Revenue by Application (2026-2031)
5.2.3 Global Cyclopentolate Revenue Market Share by Application (2020-2031)
5.3 Global Cyclopentolate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Alcon
6.1.1 Alcon Company Information
6.1.2 Alcon Description and Business Overview
6.1.3 Alcon Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Alcon Cyclopentolate Product Portfolio
6.1.5 Alcon Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Cyclopentolate Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Laboratório Edol
6.3.1 Laboratório Edol Company Information
6.3.2 Laboratório Edol Description and Business Overview
6.3.3 Laboratório Edol Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Laboratório Edol Cyclopentolate Product Portfolio
6.3.5 Laboratório Edol Recent Developments/Updates
6.4 Cadila Healthcare
6.4.1 Cadila Healthcare Company Information
6.4.2 Cadila Healthcare Description and Business Overview
6.4.3 Cadila Healthcare Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cadila Healthcare Cyclopentolate Product Portfolio
6.4.5 Cadila Healthcare Recent Developments/Updates
6.5 FDC
6.5.1 FDC Company Information
6.5.2 FDC Description and Business Overview
6.5.3 FDC Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.5.4 FDC Cyclopentolate Product Portfolio
6.5.5 FDC Recent Developments/Updates
6.6 Dr. Gerhard Mann
6.6.1 Dr. Gerhard Mann Company Information
6.6.2 Dr. Gerhard Mann Description and Business Overview
6.6.3 Dr. Gerhard Mann Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dr. Gerhard Mann Cyclopentolate Product Portfolio
6.6.5 Dr. Gerhard Mann Recent Developments/Updates
6.7 Abdi Ibrahim
6.7.1 Abdi Ibrahim Company Information
6.7.2 Abdi Ibrahim Description and Business Overview
6.7.3 Abdi Ibrahim Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abdi Ibrahim Cyclopentolate Product Portfolio
6.7.5 Abdi Ibrahim Recent Developments/Updates
6.8 Laboratorios Sophia
6.8.1 Laboratorios Sophia Company Information
6.8.2 Laboratorios Sophia Description and Business Overview
6.8.3 Laboratorios Sophia Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Laboratorios Sophia Cyclopentolate Product Portfolio
6.8.5 Laboratorios Sophia Recent Developments/Updates
6.9 Bausch and Lomb
6.9.1 Bausch and Lomb Company Information
6.9.2 Bausch and Lomb Description and Business Overview
6.9.3 Bausch and Lomb Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bausch and Lomb Cyclopentolate Product Portfolio
6.9.5 Bausch and Lomb Recent Developments/Updates
6.10 Santen
6.10.1 Santen Company Information
6.10.2 Santen Description and Business Overview
6.10.3 Santen Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Santen Cyclopentolate Product Portfolio
6.10.5 Santen Recent Developments/Updates
6.11 Riemser Arzneimittel
6.11.1 Riemser Arzneimittel Company Information
6.11.2 Riemser Arzneimittel Description and Business Overview
6.11.3 Riemser Arzneimittel Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Riemser Arzneimittel Cyclopentolate Product Portfolio
6.11.5 Riemser Arzneimittel Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Teva Cyclopentolate Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Akorn
6.13.1 Akorn Company Information
6.13.2 Akorn Description and Business Overview
6.13.3 Akorn Cyclopentolate Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Akorn Cyclopentolate Product Portfolio
6.13.5 Akorn Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cyclopentolate Industry Chain Analysis
7.2 Cyclopentolate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cyclopentolate Production Mode & Process Analysis
7.4 Cyclopentolate Sales and Marketing
7.4.1 Cyclopentolate Sales Channels
7.4.2 Cyclopentolate Distributors
7.5 Cyclopentolate Customer Analysis
8 Cyclopentolate Market Dynamics
8.1 Cyclopentolate Industry Trends
8.2 Cyclopentolate Market Drivers
8.3 Cyclopentolate Market Challenges
8.4 Cyclopentolate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Alcon
Novartis
Laboratório Edol
Cadila Healthcare
FDC
Dr. Gerhard Mann
Abdi Ibrahim
Laboratorios Sophia
Bausch and Lomb
Santen
Riemser Arzneimittel
TEVA
Akorn
List of Tables
 Table 1. Global Cyclopentolate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cyclopentolate Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cyclopentolate Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cyclopentolate Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Cyclopentolate Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cyclopentolate Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cyclopentolate Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cyclopentolate Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cyclopentolate, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cyclopentolate, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cyclopentolate, Product Type & Application
 Table 12. Global Key Manufacturers of Cyclopentolate, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cyclopentolate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclopentolate as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cyclopentolate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cyclopentolate Sales by Region (2020-2025) & (K Units)
 Table 18. Global Cyclopentolate Sales Market Share by Region (2020-2025)
 Table 19. Global Cyclopentolate Sales by Region (2026-2031) & (K Units)
 Table 20. Global Cyclopentolate Sales Market Share by Region (2026-2031)
 Table 21. Global Cyclopentolate Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cyclopentolate Revenue Market Share by Region (2020-2025)
 Table 23. Global Cyclopentolate Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cyclopentolate Revenue Market Share by Region (2026-2031)
 Table 25. North America Cyclopentolate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cyclopentolate Sales by Country (2020-2025) & (K Units)
 Table 27. North America Cyclopentolate Sales by Country (2026-2031) & (K Units)
 Table 28. North America Cyclopentolate Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cyclopentolate Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cyclopentolate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cyclopentolate Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Cyclopentolate Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Cyclopentolate Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cyclopentolate Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cyclopentolate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cyclopentolate Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Cyclopentolate Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Cyclopentolate Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cyclopentolate Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cyclopentolate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cyclopentolate Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Cyclopentolate Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Cyclopentolate Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cyclopentolate Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cyclopentolate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cyclopentolate Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Cyclopentolate Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Cyclopentolate Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cyclopentolate Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cyclopentolate Sales (K Units) by Type (2020-2025)
 Table 51. Global Cyclopentolate Sales (K Units) by Type (2026-2031)
 Table 52. Global Cyclopentolate Sales Market Share by Type (2020-2025)
 Table 53. Global Cyclopentolate Sales Market Share by Type (2026-2031)
 Table 54. Global Cyclopentolate Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cyclopentolate Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cyclopentolate Revenue Market Share by Type (2020-2025)
 Table 57. Global Cyclopentolate Revenue Market Share by Type (2026-2031)
 Table 58. Global Cyclopentolate Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Cyclopentolate Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Cyclopentolate Sales (K Units) by Application (2020-2025)
 Table 61. Global Cyclopentolate Sales (K Units) by Application (2026-2031)
 Table 62. Global Cyclopentolate Sales Market Share by Application (2020-2025)
 Table 63. Global Cyclopentolate Sales Market Share by Application (2026-2031)
 Table 64. Global Cyclopentolate Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cyclopentolate Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cyclopentolate Revenue Market Share by Application (2020-2025)
 Table 67. Global Cyclopentolate Revenue Market Share by Application (2026-2031)
 Table 68. Global Cyclopentolate Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Cyclopentolate Price (US$/Unit) by Application (2026-2031)
 Table 70. Alcon Company Information
 Table 71. Alcon Description and Business Overview
 Table 72. Alcon Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Alcon Cyclopentolate Product
 Table 74. Alcon Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Novartis Cyclopentolate Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Laboratório Edol Company Information
 Table 81. Laboratório Edol Description and Business Overview
 Table 82. Laboratório Edol Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Laboratório Edol Cyclopentolate Product
 Table 84. Laboratório Edol Recent Developments/Updates
 Table 85. Cadila Healthcare Company Information
 Table 86. Cadila Healthcare Description and Business Overview
 Table 87. Cadila Healthcare Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Cadila Healthcare Cyclopentolate Product
 Table 89. Cadila Healthcare Recent Developments/Updates
 Table 90. FDC Company Information
 Table 91. FDC Description and Business Overview
 Table 92. FDC Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. FDC Cyclopentolate Product
 Table 94. FDC Recent Developments/Updates
 Table 95. Dr. Gerhard Mann Company Information
 Table 96. Dr. Gerhard Mann Description and Business Overview
 Table 97. Dr. Gerhard Mann Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Dr. Gerhard Mann Cyclopentolate Product
 Table 99. Dr. Gerhard Mann Recent Developments/Updates
 Table 100. Abdi Ibrahim Company Information
 Table 101. Abdi Ibrahim Description and Business Overview
 Table 102. Abdi Ibrahim Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Abdi Ibrahim Cyclopentolate Product
 Table 104. Abdi Ibrahim Recent Developments/Updates
 Table 105. Laboratorios Sophia Company Information
 Table 106. Laboratorios Sophia Description and Business Overview
 Table 107. Laboratorios Sophia Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Laboratorios Sophia Cyclopentolate Product
 Table 109. Laboratorios Sophia Recent Developments/Updates
 Table 110. Bausch and Lomb Company Information
 Table 111. Bausch and Lomb Description and Business Overview
 Table 112. Bausch and Lomb Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Bausch and Lomb Cyclopentolate Product
 Table 114. Bausch and Lomb Recent Developments/Updates
 Table 115. Santen Company Information
 Table 116. Santen Description and Business Overview
 Table 117. Santen Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Santen Cyclopentolate Product
 Table 119. Santen Recent Developments/Updates
 Table 120. Riemser Arzneimittel Company Information
 Table 121. Riemser Arzneimittel Description and Business Overview
 Table 122. Riemser Arzneimittel Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Riemser Arzneimittel Cyclopentolate Product
 Table 124. Riemser Arzneimittel Recent Developments/Updates
 Table 125. Teva Company Information
 Table 126. Teva Description and Business Overview
 Table 127. Teva Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Teva Cyclopentolate Product
 Table 129. Teva Recent Developments/Updates
 Table 130. Akorn Company Information
 Table 131. Akorn Description and Business Overview
 Table 132. Akorn Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Akorn Cyclopentolate Product
 Table 134. Akorn Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Cyclopentolate Distributors List
 Table 138. Cyclopentolate Customers List
 Table 139. Cyclopentolate Market Trends
 Table 140. Cyclopentolate Market Drivers
 Table 141. Cyclopentolate Market Challenges
 Table 142. Cyclopentolate Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cyclopentolate
 Figure 2. Global Cyclopentolate Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cyclopentolate Market Share by Type: 2024 & 2031
 Figure 4. Patent Product Picture
 Figure 5. Generic Product Picture
 Figure 6. Global Cyclopentolate Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cyclopentolate Market Share by Application: 2024 & 2031
 Figure 8. Mydriatic Agent
 Figure 9. Muscarinic Receptor Antagonist
 Figure 10. Global Cyclopentolate Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Cyclopentolate Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Cyclopentolate Sales (2020-2031) & (K Units)
 Figure 13. Global Cyclopentolate Average Price (US$/Unit) & (2020-2031)
 Figure 14. Cyclopentolate Report Years Considered
 Figure 15. Cyclopentolate Sales Share by Manufacturers in 2024
 Figure 16. Global Cyclopentolate Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Cyclopentolate Players: Market Share by Revenue in Cyclopentolate in 2024
 Figure 18. Cyclopentolate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Cyclopentolate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Cyclopentolate Sales Market Share by Country (2020-2031)
 Figure 21. North America Cyclopentolate Revenue Market Share by Country (2020-2031)
 Figure 22. United States Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Cyclopentolate Sales Market Share by Country (2020-2031)
 Figure 25. Europe Cyclopentolate Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Cyclopentolate Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Cyclopentolate Revenue Market Share by Region (2020-2031)
 Figure 33. China Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Cyclopentolate Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Cyclopentolate Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Cyclopentolate Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Cyclopentolate Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Cyclopentolate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Cyclopentolate by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Cyclopentolate by Type (2020-2031)
 Figure 54. Global Cyclopentolate Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Cyclopentolate by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Cyclopentolate by Application (2020-2031)
 Figure 57. Global Cyclopentolate Price (US$/Unit) by Application (2020-2031)
 Figure 58. Cyclopentolate Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Myopic Eye Drop Market Research Report 2024
Global Atropine Eye Drop Market Research Report 2024
Global Atropine Myopia Control Eye Drops Market Research Report 2024
Global Atropine Sulfate Eye Drop Market Research Report 2024
Global Low Concentration Atropine Myopia Control Eye Drops Market Research Report 2024
Global Atropine Market Insights Forecast to 2030
Global Pilocarpine Market Research Report 2024
Global Cyclosporine Eye Drop Market Research Report 2024
Global Eye Drops and Lubricants Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Cyclopentylamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Physostigmine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antazoline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Eye Drops Lubricants Market Insights Forecast to 2030
Global Atropine Eye Drops for Myopia Control Market Research Report 2024
Global Low concentration Atropine Eye Drops Market Research Report 2024
Tropicamide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Eye Drops Artificial Tear Market Research Report 2025
Global Low Concentration Atropine Eye Drop Market Research Report 2024
Global Olopatadine Hydrochloride Eye Drops Market Research Report 2024
Global Pharmaceutical Grade Tropicamide Market Research Report 2024

RELATED REPORTS

Global High Acuity Care Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5D18285
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global mHealth (Mobile Health) Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B6151
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Resin Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21S7871
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mobile Medical Imaging Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16Q6154
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions